Go Pro

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$49.16 -2.20 (-4.28%)
Closing price 07/14/2026 03:59 PM Eastern
Extended Trading
$49.67 +0.51 (+1.04%)
As of 07/14/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. BLCO, LIVN, MMED, NVST, and IRTC

Should you buy Inspire Medical Systems stock or one of its competitors? MarketBeat compares Inspire Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspire Medical Systems include Bausch + Lomb (BLCO), LivaNova (LIVN), MiniMed Group (MMED), Envista (NVST), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

How does Inspire Medical Systems compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Inspire Medical Systems has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$5.10B1.12-$360M-$0.62N/A
Inspire Medical Systems$911.98M1.55$145.42M$4.4910.95

In the previous week, Bausch + Lomb had 4 more articles in the media than Inspire Medical Systems. MarketBeat recorded 7 mentions for Bausch + Lomb and 3 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 0.88 beat Bausch + Lomb's score of 0.47 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bausch + Lomb has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market.

Inspire Medical Systems has a net margin of 14.33% compared to Bausch + Lomb's net margin of -4.21%. Inspire Medical Systems' return on equity of 10.35% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-4.21% 3.60% 1.69%
Inspire Medical Systems 14.33%10.35%8.81%

Bausch + Lomb presently has a consensus target price of $18.00, suggesting a potential upside of 12.82%. Inspire Medical Systems has a consensus target price of $81.05, suggesting a potential upside of 64.88%. Given Inspire Medical Systems' higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.21
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19

Summary

Inspire Medical Systems beats Bausch + Lomb on 13 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to LivaNova?

Inspire Medical Systems (NYSE:INSP) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, Inspire Medical Systems and Inspire Medical Systems both had 3 articles in the media. LivaNova's average media sentiment score of 1.51 beat Inspire Medical Systems' score of 0.88 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Inspire Medical Systems has a net margin of 14.33% compared to LivaNova's net margin of 7.48%. LivaNova's return on equity of 16.48% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
LivaNova 7.48%16.48%7.59%

Inspire Medical Systems has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Inspire Medical Systems has higher earnings, but lower revenue than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.55$145.42M$4.4910.95
LivaNova$1.39B3.13-$242.47M$1.9540.57

Inspire Medical Systems presently has a consensus target price of $81.05, indicating a potential upside of 64.88%. LivaNova has a consensus target price of $80.75, indicating a potential upside of 2.06%. Given Inspire Medical Systems' higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19
LivaNova
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

LivaNova beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Inspire Medical Systems (NYSE:INSP) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

MiniMed Group presently has a consensus target price of $21.33, indicating a potential upside of 41.84%. Inspire Medical Systems has a consensus target price of $81.05, indicating a potential upside of 64.88%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than MiniMed Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.73
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19

Inspire Medical Systems has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$3.10B1.36-$190.97M-$0.68N/A
Inspire Medical Systems$911.98M1.55$145.42M$4.4910.95

In the previous week, MiniMed Group had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 6 mentions for MiniMed Group and 3 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 0.88 beat MiniMed Group's score of 0.81 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiniMed Group
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

19.7% of MiniMed Group shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 2.2% of MiniMed Group shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Inspire Medical Systems has a net margin of 14.33% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 10.35% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Inspire Medical Systems 14.33%10.35%8.81%

Summary

Inspire Medical Systems beats MiniMed Group on 12 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Envista?

Envista (NYSE:NVST) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Envista has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

In the previous week, Envista had 2 more articles in the media than Inspire Medical Systems. MarketBeat recorded 5 mentions for Envista and 3 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 0.88 beat Envista's score of 0.65 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.9% of Inspire Medical Systems shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Inspire Medical Systems has lower revenue, but higher earnings than Envista. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.56$47M$0.4163.73
Inspire Medical Systems$911.98M1.55$145.42M$4.4910.95

Inspire Medical Systems has a net margin of 14.33% compared to Envista's net margin of 2.41%. Inspire Medical Systems' return on equity of 10.35% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Inspire Medical Systems 14.33%10.35%8.81%

Envista currently has a consensus target price of $28.54, suggesting a potential upside of 9.21%. Inspire Medical Systems has a consensus target price of $81.05, suggesting a potential upside of 64.88%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19

Summary

Inspire Medical Systems beats Envista on 10 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

iRhythm Technologies presently has a consensus target price of $187.38, indicating a potential upside of 66.49%. Inspire Medical Systems has a consensus target price of $81.05, indicating a potential upside of 64.88%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe iRhythm Technologies is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19

In the previous week, iRhythm Technologies and iRhythm Technologies both had 3 articles in the media. Inspire Medical Systems' average media sentiment score of 0.88 beat iRhythm Technologies' score of 0.62 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M4.95-$44.55M-$0.86N/A
Inspire Medical Systems$911.98M1.55$145.42M$4.4910.95

iRhythm Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

Inspire Medical Systems has a net margin of 14.33% compared to iRhythm Technologies' net margin of -3.53%. Inspire Medical Systems' return on equity of 10.35% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-3.53% -10.26% -1.39%
Inspire Medical Systems 14.33%10.35%8.81%

94.9% of Inspire Medical Systems shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Inspire Medical Systems beats iRhythm Technologies on 10 of the 16 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$1.48B$1.84B$6.86B$23.45B
Dividend YieldN/AN/A2.68%4.02%
P/E Ratio10.9576.8427.0131.16
Price / Sales1.557.81522.3419.76
Price / Cash17.9327.7348.5924.88
Price / Book1.835.6010.804.78
Net Income$145.42M-$54.76M$3.59B$1.07B
7 Day Performance-0.35%-0.50%-1.49%0.78%
1 Month Performance19.67%3.53%2.79%0.21%
1 Year Performance-61.54%0.19%28.56%18.52%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
4.2171 of 5 stars
$49.16
-4.3%
$81.05
+64.9%
-62.2%$1.48B$911.98M10.951,333
BLCO
Bausch + Lomb
3.8235 of 5 stars
$16.25
+0.1%
$18.00
+10.8%
+16.8%$5.80B$5.10BN/A13,000
LIVN
LivaNova
2.2671 of 5 stars
$82.98
+0.5%
$80.75
-2.7%
+79.9%$4.54B$1.39B42.553,300
MMED
MiniMed Group
2.671 of 5 stars
$16.10
+5.3%
$21.33
+32.5%
N/A$4.52B$3.10BN/A8,000
NVST
Envista
2.4309 of 5 stars
$26.23
+1.2%
$28.54
+8.8%
+30.4%$4.22B$2.72B63.9712,000

Related Companies and Tools


This page (NYSE:INSP) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners